What USDOJ and SEC Now Expect from Pharmaceutical, Biotechnology, Medical Device Companies, and CRO's (New York, NY)

What USDOJ and SEC Now Expect from Pharmaceutical, Biotechnology, Medical Device Companies, and CRO's (New York, NY)

Event Date(s): 04/27/2015

Tim participated as a panelist discussing FCPA and anticorruption in pharmaceuticals and life sciences at the American Conference Institute (ACI) 10th Advanced Conference on FCPA & Anti-Corruption for the Life Sciences Industry. U.S. and international enforcement authorities have continued their vigorous pursuit of life sciences companies for FCPA and anti-corruption violations, resulting in recent high profile investigations across the globe and heightened government compliance expectations. ACI’s conference provides a forum for the key players - top federal prosecutors, preeminent corporate counsel, and leading FCPA practitioners - to come together for critical networking and benchmarking on how to combat the next wave of global anti-corruption risk factors confronting the industry.

Event Link: http://fcpaconference.com/pharma/